Design of the novel ThermoBrachy applicators enabling simultaneous interstitial hyperthermia and high dose rate brachytherapy

References

• Thiruthaneeswaran N, Hoskin PJ. High dose rate brachytherapy for prostate cancer: standard of care and future direction. Cancer Radiother. 2016;20(1):66–72.
   PubMed Web of Science ®Google Scholar
• Chin J, Rumble RB, Kollmeier M, et al. Brachytherapy for patients with prostate cancer: American Society of Clinical Oncology/Cancer Care Ontario joint guideline update. J Clin Oncol. 2017;35(15):1737–1743.
   PubMed Web of Science ®Google Scholar
• Demanes DJ, Ghilezan MI. High-dose-rate brachytherapy as monotherapy for prostate cancer. Brachytherapy. 2014;13(6):529–541.
   PubMed Web of Science ®Google Scholar
• Aluwini S, Pos F, Schimmel E, et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. The Lancet Oncology. 2015;16(3):274–283.
   PubMed Web of Science ®Google Scholar
• Morton GC, Hoskin PJ. Brachytherapy: current status and future strategies – can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol. 2013;25(8):474–482.
   Web of Science ®Google Scholar
• Kollmeier MA, McBride S, Taggar A, et al. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: a comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time. Brachytherapy. 2017;16(6):1091–1098.
   PubMed Web of Science ®Google Scholar
• Murgic J, Morton G, Loblaw A, et al. Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2018;102(3):561–567.
   PubMed Web of Science ®Google Scholar
• Chatzikonstantinou G, Zamboglou N, Rödel C, et al. High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : a systematic review. Strahlenther Onkol. 2017;193(9):683–691.
   PubMed Web of Science ®Google Scholar
• Tselis N, Hoskin P, Baltas D, et al. High dose rate brachytherapy as monotherapy for localised prostate cancer: review of the current status. Clin Oncol. 2017;29(7):401–411.
   Web of Science ®Google Scholar
• Mendez LC, Ravi A, Chung H, et al. Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapy. Brachytherapy. 2018;17(2):291–297.
   PubMed Web of Science ®Google Scholar
• Armstrong S, Tsang Y, Lowe G, et al. Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer. Radiother Oncol. 2021;157:93–98.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol. 2007;19(6):418–426.
   PubMed Web of Science ®Google Scholar
• Datta NR, Ordóñez SG, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 2015;41(9):742–753.
   PubMed Web of Science ®Google Scholar
• Datta NR, Bodis S. Hyperthermia with radiotherapy reduces tumour alpha/beta: Insights from trials of thermoradiotherapy vs radiotherapy alone. Radiother Oncol. 2019;138:1–8.
   PubMed Web of Science ®Google Scholar
• Ryu S, Brown SL, Kim S-H, et al. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys. 1996;34(1):133–138.
   PubMed Web of Science ®Google Scholar
• Pajonk F, van Ophoven A, McBride WH. Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Res. 2005;65(11):4836–4843.
   PubMed Web of Science ®Google Scholar
• Tilly W, Gellermann J, Graf R, et al. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol. 2005;181(1):35–41.
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Hansen JL, Prokopios‐Davos S, et al. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute Study 94-153. Cancer. 2011;117(3):510–516.
   PubMed Web of Science ®Google Scholar
• Maluta S, Dall'Oglio S, Romano M, et al. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Int J Hyperthermia. 2007;23(5):451–456.
   PubMed Web of Science ®Google Scholar
• Prionas SD, Kapp DS, Goffinet DR, et al. Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1994;28(1):151–162.
   PubMed Web of Science ®Google Scholar
• Kukiełka AM, Hetnał M, Brandys P, et al. Interstitial hyperthermia of the prostate in combination with brachytherapy: an evaluation of feasibility and early tolerance. Strahlenther Onkol. 2013;189(6):467–475.
   PubMed Web of Science ®Google Scholar
• van Vulpen M, Raaymakers BW, Lagendijk JJW, et al. Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma—a feasibility study. Int J Radiat Oncol Biol Phys. 2002;53(1):116–126.
   PubMed Web of Science ®Google Scholar
• Williams VL, Puthawala A, Phan TP, et al. Interstitial hyperthermia during HDR brachytherapy monotherapy for treatment of early stage prostate cancer with benign prostate hyperplasia (BPH). Brachytherapy. 2007;6(2):86.
   Google Scholar
• Dobšíček Trefná H, Schmidt M, van Rhoon GC, et al. Quality assurance guidelines for interstitial hyperthermia. Int J Hyperthermia. 2019;36(1):277–294.
   PubMed Web of Science ®Google Scholar
• Kok HP, van Haaren PM, van de Kamer JB, et al. Theoretical comparison of intraluminal heating techniques. Int J Hyperthermia. 2007;23(4):395–411.
   PubMed Web of Science ®Google Scholar
• Marchal C, Nadi M, Hoffstetter S, et al. Practical interstitial method of heating operating at 27.12 MHz. Int J Hyperthermia. 1989;5(4):451–466.
   PubMed Web of Science ®Google Scholar
• Visser AG, Deurloo IKK, Levendag PC, et al. An interstitial hyperthermia system at 27 MHz. Int J Hyperthermia. 1989;5(2):265–276.
   PubMed Web of Science ®Google Scholar
• Deurloo IKK, Visser AG, Morawska M, et al. Application of a capacitive-coupling interstitial hyperthermia system at 27 MHz: study of different applicator configurations. Phys Med Biol. 1991;36(1):119–132.
   PubMed Web of Science ®Google Scholar
• Kaatee RSJP, Crezee H, Kanis BP, et al. Spatial temperature control with a 27 MHz current source interstitial hyperthermia system. Int J Radiat Oncol Biol Phys. 1997;37(1):189–197.
   PubMed Web of Science ®Google Scholar
• Van der Koijk JF, Crezee J, Van Leeuwen GMJ, et al. Dose uniformity in MECS interstitial hyperthermia: the impact of longitudinal control in model anatomies. Phys Med Biol. 1996;41(3):429–444.
   PubMed Web of Science ®Google Scholar
• Raaymakers BW, Van Vulpen M, Lagendijk JJW, et al. Determination and validation of the actual 3D temperature distribution during interstitial hyperthermia of prostate carcinoma. Phys Med Biol. 2001;46(12):3115–3131.
   PubMed Web of Science ®Google Scholar
• Hulshof M, Raaymakers BW, Lagendijk JJW, et al. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the multi electrode current source (MECS) system. Int J Hyperthermia. 2004;20(5):451–463.
   PubMed Web of Science ®Google Scholar
• van Vulpen M, Raaymakers BW, de Leeuw AAC, et al. Prostate perfusion in patients with locally advanced prostate carcinoma treated with different hyperthermia techniques. J Urol. 2002;168(4 Part 1):1597–1602.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Colombo A, Henry A, et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update. Radiother Oncol. 2013;107(3):325–332.
   PubMed Web of Science ®Google Scholar
• Dewey WC, Hopwood LE, Sapareto SA, et al. Cellular responses to combinations of hyperthermia and radiation. Radiology. 1977;123(2):463–474.
   PubMed Web of Science ®Google Scholar
• Xu M, Wright WD, Higashikubo R, et al. Thermal radiosensitization of human tumour cell lines with different sensitivities to 41.1 degrees C. Int J Hypertherm. 1999;15(4):279–290.
   PubMed Web of Science ®Google Scholar
• Overgaard J. The heat is (still) on-the past and future of hyperthermic radiation oncology. Radiother Oncol. 2013;109(2):185–187.
   PubMed Web of Science ®Google Scholar
• Van der Koijk JF, Crezee J, Lagendijk JJW. Thermal properties of capacitively coupled electrodes in interstitial hyperthermia. Phys Med Biol. 1998;43(1):139–153.
   PubMed Web of Science ®Google Scholar
• Van der Koijk JF, Lagendijk JJW, Crezee J, et al. The influence of vasculature on temperature distributions in MECS interstitial hyperthermia: importance of longitudinal control. Int J Hyperthermia. 1997;13(4):365–385.
   PubMed Web of Science ®Google Scholar
• Chang TY, Yadav VG, De Leo S, et al. Cell and protein compatibility of parylene-C surfaces. Langmuir. 2007;23(23):11718–11725.
   PubMed Web of Science ®Google Scholar
• Gaudreault M, Reniers B, Landry G, et al. Dose perturbation due to catheter materials in high-dose-rate interstitial (192)Ir brachytherapy. Brachytherapy. 2014;13(6):627–631.
   PubMed Web of Science ®Google Scholar
• Hubbell JH, Seltzer SM. Tables of X-ray mass attenuation coefficients and mass energy-absorption coefficients 1 keV to 20 MeV for elements Z = 1–92 and 48 additional substances of dosimetric interest. Gaithersburg, MD (USA): National Institute of Standards and Technology-PL; 1995.
   Google Scholar
• Kaatee RSJP, Crezee H, Visser AG. Temperature measurement errors with thermocouples inside 27 MHz current source interstitial hyperthermia applicators. Phys Med Biol. 1999;44(6):1499–1511.
   PubMed Web of Science ®Google Scholar
• Khawaji IH, Chindam C, Awadelkarim OO, et al. Dielectric properties of and charge transport in columnar microfibrous thin films of parylene C. IEEE Trans Electron Devices. 2017;64(8):3360–3367.
   Web of Science ®Google Scholar
• Kahouli A, Sylvestre A, Jomni F, et al. Experimental and theoretical study of AC electrical conduction mechanisms of semicrystalline parylene C thin films. J Phys Chem A. 2012;116(3):1051–1058.
   PubMed Web of Science ®Google Scholar
• Hasgall PA, Di Gennaro F, Baumgartner C, et al. IT’IS database for thermal and electromagnetic parameters of biological tissues. Version 4.0. 2018 May 15, 2018.
   Google Scholar
• Yee K. Numerical solution of initial boundary value problems involving maxwell's equations in isotropic media. IEEE Trans Antennas Propag. 1966;14(3):302–307.
   Google Scholar
• Pennes H. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1(2):93–122.
   PubMed Web of Science ®Google Scholar
• Kaiser M, Detert M, Rube MA, et al. Resonant marker design and fabrication techniques for device visualization during interventional magnetic resonance imaging. Biomedizinische Technik. [Biomed Eng]. 2015;60(2):89–103.
   PubMed Web of Science ®Google Scholar
• Baysoy E, Yildirim DK, Ozsoy C, et al. Thin film based semi-active resonant marker design for low profile interventional cardiovascular MRI devices. Magnetic resonance materials in physics. MAGMA. 2017;30(1):93–101.
   PubMedGoogle Scholar
• Wheeler HA. Formulas for the skin effect. Proc Ire. 1942;30(9):412–424.
   Google Scholar
• Rijnen Z, Bakker JF, Canters RAM, et al. Clinical integration of software tool VEDO for adaptive and quantitative application of phased array hyperthermia in the head and neck. Int J Hyperthermia. 2013;29(3):181–193.
   PubMed Web of Science ®Google Scholar
• Kok HP, Kotte A, Crezee J. Planning, optimisation and evaluation of hyperthermia treatments. Int J Hyperthermia. 2017;33(6):593–607.
   PubMed Web of Science ®Google Scholar
• Breedveld S, Bennan ABA, Aluwini S, et al. Fast automated multi-criteria planning for HDR brachytherapy explored for prostate cancer. Phys Med Biol. 2019;64(20):205002.
   PubMed Web of Science ®Google Scholar
• de Bree J, Van der Koijk JF, Lagendijk JJW. A 3-D SAR model for current source interstitial hyperthermia. IEEE Trans Biomed Eng. 1996;43(10):1038–1045.
   PubMed Web of Science ®Google Scholar